Christopher Stevens
Equibles does not estimate personal net worth.
Get an email with a short summary when Rocket Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get RCKT alertsAbout Christopher Stevens
Christopher Stevens is recorded as COO at Rocket Pharmaceuticals, Inc. (RCKT). The newest filing on record that lists Christopher Stevens as COO at Rocket Pharmaceuticals, Inc. (RCKT) is dated April 6, 2026. Rocket Pharmaceuticals, Inc. reported in an 8-K filed July 11, 2025 that Christopher Stevens was appointed Chief Operating Officer, effective July 7, 2025. The proxy statement of Rocket Pharmaceuticals, Inc. reports total compensation of $3,555,467 for Christopher Stevens in fiscal 2025, including a base salary of $242,308. Rocket Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rocket Pharmaceuticals, Inc. includes Gaurav Shah (CEO and Board Member), Aaron Ondrey (CFO), Carlos Garcia-Parada (CFO) and 7 others.
“On July 7, 2025, Christopher Stevens was appointed by Rocket Pharmaceuticals, Inc. (the "Company") as the Company's Chief Operating Officer.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 6, 2026
Company network
Leadership on record at Rocket Pharmaceuticals, Inc.
- Gaurav Shah CEO, Board Member
- Aaron Ondrey CFO
- Carlos Garcia-Parada CFO
- John Militello CFO
- Chris Stevens COO
- Martin Wilson General Counsel
- Joseph Manhede Chief Accounting Officer
- Carsten Boess Board Member
- David P. Southwell Board Member
- Dr. Mikael Dolsten, M.D., Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Rocket Pharmaceuticals, Inc. (RCKT) | Chief Operating Officer | $242,308 | $3,555,467 |